Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancer.
Dell'Oglio P, Karnes RJ, Joniau S, Spahn M, Gontero P, Tosco L, Fossati N, Kneitz B, Chlosta P, Graefen M, Marchioro G, Bianchi M, Sanchez-Salas R, Karakiewicz PI, Poppel HV, Montorsi F, Briganti A; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). Dell'Oglio P, et al. Among authors: chlosta p. Urol Oncol. 2016 May;34(5):234.e13-9. doi: 10.1016/j.urolonc.2015.11.018. Epub 2015 Dec 17. Urol Oncol. 2016. PMID: 26706120
Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy.
Sivaraman A, Ordaz Jurado G, Cathelineau X, Barret E, Dell'Oglio P, Joniau S, Bianchi M, Briganti A, Spahn M, Bastian P, Chun J, Chlosta P, Gontero P, Graefen M, Jeffrey Karnes R, Marchioro G, Tombal B, Tosco L, van der Poel HH, Sanchez-Salas R. Sivaraman A, et al. Among authors: chlosta p. World J Urol. 2016 Oct;34(10):1367-72. doi: 10.1007/s00345-016-1784-8. Epub 2016 Feb 20. World J Urol. 2016. PMID: 26897499 Free article.
Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.
Módos O, Reis H, Niedworok C, Rübben H, Szendröi A, Szász MA, Tímár J, Baghy K, Kovalszky I, Golabek T, Chlosta P, Okon K, Peyronnet B, Mathieu R, Shariat SF, Hollósi P, Nyirády P, Szarvas T. Módos O, et al. Among authors: chlosta p. Oncotarget. 2016 Jun 28;7(26):39293-39301. doi: 10.18632/oncotarget.9828. Oncotarget. 2016. PMID: 27283768 Free PMC article.
Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection.
Moris L, Van den Broeck T, Tosco L, Van Baelen A, Gontero P, Karnes RJ, Everaerts W, Albersen M, Bastian PJ, Chlosta P, Claessens F, Chun FK, Graefen M, Gratzke C, Kneitz B, Marchioro G, Salas RS, Tombal B, Van Der Poel H, Walz JC, De Meerleer G, Bossi A, Haustermans K, Montorsi F, Van Poppel H, Spahn M, Briganti A, Joniau S. Moris L, et al. Among authors: chlosta p. Front Surg. 2016 Dec 16;3:65. doi: 10.3389/fsurg.2016.00065. eCollection 2016. Front Surg. 2016. PMID: 28018903 Free PMC article.
Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy.
Moschini M, Foerster B, Abufaraj M, Soria F, Seisen T, Roupret M, Colin P, De la Taille A, Peyronnet B, Bensalah K, Herout R, Wirth MP, Novotny V, Chlosta P, Bandini M, Montorsi F, Simone G, Gallucci M, Romeo G, Matsumoto K, Karakiewicz P, Briganti A, Shariat SF. Moschini M, et al. Among authors: chlosta p. World J Urol. 2017 Oct;35(10):1541-1547. doi: 10.1007/s00345-017-2026-4. Epub 2017 Feb 28. World J Urol. 2017. PMID: 28247066
The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer.
Tosco L, Laenen A, Briganti A, Gontero P, Karnes RJ, Albersen M, Bastian PJ, Chlosta P, Claessens F, Chun FK, Everaerts W, Gratzke C, Graefen M, Kneitz B, Marchioro G, Salas RS, Tombal B, Van den Broeck T, Moris L, Battaglia A, van der Poel H, Walz J, Bossi A, De Meerleer G, Haustermans K, Van Poppel H, Spahn M, Joniau S. Tosco L, et al. Among authors: chlosta p. Prostate Cancer Prostatic Dis. 2017 Dec;20(4):407-412. doi: 10.1038/pcan.2017.29. Epub 2017 May 9. Prostate Cancer Prostatic Dis. 2017. PMID: 28485390
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis.
Tosco L, Laenen A, Briganti A, Gontero P, Karnes RJ, Bastian PJ, Chlosta P, Claessens F, Chun FK, Everaerts W, Gratzke C, Albersen M, Graefen M, Kneitz B, Marchioro G, Salas RS, Tombal B, Van den Broeck T, Van Der Poel H, Walz J, De Meerleer G, Bossi A, Haustermans K, Van Poppel H, Spahn M, Joniau S; European Multicenter Prostate Cancer Clinical and Translational Research group (EMPaCT). Tosco L, et al. Among authors: chlosta p. Eur Urol Focus. 2018 Apr;4(3):369-375. doi: 10.1016/j.euf.2016.12.008. Epub 2017 Jan 17. Eur Urol Focus. 2018. PMID: 28753838 Clinical Trial.
Chromium in urothelial carcinoma of the bladder.
Golabek T, Socha K, Kudelski J, Darewicz B, Markiewicz-Zukowska R, Chlosta P, Borawska M. Golabek T, et al. Among authors: chlosta p. Ann Agric Environ Med. 2017 Dec 23;24(4):602-605. doi: 10.5604/12321966.1232760. Epub 2017 May 11. Ann Agric Environ Med. 2017. PMID: 29284232 Free article.
218 results